Minute virus of mice: Antibody response, viral shedding, and persistence of viral DNA in multiple strains of mice

Comparative Medicine

Volumn 58, Issue 4, 2008, Pages 360-368

  Janus, Lydia M ^a   Mähler, Michael ^b   Köhl, Wiebke ^b   Smoczek, Anna ^a   Hedrich, Hans J ^a   Bleich, Andre ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Biomedical Diagnostics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPLOTYPE; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; RISK FACTOR; SEROCONVERSION; SEROLOGY; VIRUS LOAD; VIRUS SHEDDING;

ANIMALS; ANTIBODIES; DNA, VIRAL; FECES; FEMALE; HAPLOTYPES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED STRAINS; MINUTE VIRUS OF MICE; PARVOVIRIDAE INFECTIONS; RODENT DISEASES; VIRAL LOAD; VIRUS SHEDDING;

EID: 51549102384     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bauer BA, Riley LK. 2006. Antemortem detection of mouse parvovirus and mice minute virus by polymerase chain reaction (PCR) of faecal samples. Lab Anim 40:144-152.
2. Besselsen DG, Wagner AM, Loganbill JK. 2000. Effect of mouse strain and age on detection of mouse parvovirus 1 by use of serologic testing and polymerase chain reaction analysis. Comp Med 50:498-502.
3. Bleich A, Mähler M. 2005. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and Helicobacter-induced gastritis. Pathobiology 72:293-307.
4. Bonnard GD, Manders EK, Campell DA Jr, Herberman RB, Collins MJ Jr. 1976. Immunosuppressive activity of a subline of the mouse EL4 lymphoma. Evidence for minute virus of mice causing the inhibition. J Exp Med 143:187-205.
5. Brownstein DG, Smith AL, Jacoby RO, Johnson EA, Hansen G, Tattersall P. 1991. Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest 65:357-364.
6. Crawford LV. 1966. A minute virus of mice. Virology 29:605-612.
7. Engers HD, Louis JA, Zubler RH, Hirt B. 1981. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice. J Immunol 127:2280-2285.
8. Guetta E, Graziani Y, Tal J. 1986. Suppression of Ehrlich ascites tumors in mice by minute virus of mice. J Natl Cancer Inst 76:1177-1180.
9. Heldt CL, Hernandez R, Mudiganti U, Gurgel PV, Brown DT, Carbonell RG. 2006. A colorimetric assay for viral agents that produce cytopathic effects. J Virol Methods 135:56-65.
10. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. 1995. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 181:713-721.
11. Jacoby RO, Ball-Goodrich LJ, Besselsen DG, McKisic MD, Riley LK, Smith AL. 1996. Rodent parvovirus infections. Lab Anim Sci 46:370-380.
12. Jacoby RO, Johnson EA, Paturzo FX, Ball-Goodrich L. 2000. Persistent rat virus infection in smooth muscle of euthymic and athymic rats. J Virol 74:11841-11848.
13. KaerberG.1931.Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche.Arch Exp Pathol Pharmakol162:480-483.
14. Kilham L, Margolis G. 1970. Pathogenicity of minute virus of mice (MVM) for rats, mice and hamsters. Proc Soc Exp Biol Med 133:1447-1452.
15. Lamana ML, Albella B, Bueren JA, Segovia JC. 2001. In vitro and in vivo susceptibility of mouse megakaryocytic progenitors to strain i of parvovirus minute virus of mice. Exp Hematol 29:1303-1309.
16. Lefrere JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrere F, Girot R, Allain JP, Laperche S. 2005. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 106:2890-2895.
17. Livingston RS, Besselsen DG, Steffen EK, Besch-Williford CL, Franklin CL, Riley LK. 2002. Serodiagnosis of mice minute virus and mouse parvovirus infections in mice by enzyme-linked immunosorbent assay with baculovirus-expressed recombinant VP2 proteins. Clin Diagn Lab Immunol 9:1025-1031.
18. Mousset S, Rommelaere J. 1982. Minute virus of mice inhibits cell transformation by simian virus 40. Nature 300:537-539.
19. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke BFELASA. 2002. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 36:20-42.
20. Nicklas W, Kraft V, Meyer B. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab Anim Sci 43:296-300.
21. Redig AJ, Besselsen DG. 2001. Detection of rodent parvoviruses by use of fluorogenic nuclease polymerase chain reaction assays. Comp Med 51:326-331.
22. Segovia JC, Real A, Bueren JA, Almendral JM. 1991. In vitro myelosuppressive effects of the parvovirus minute virus of mice (MVMi) on hematopoietic stem and committed progenitor cells. Blood 77:980-988.
23. Singleton GR, Smith AL, Shellam GR, Fitzgerald N, Muller WJ. 1993. Prevalence of viral antibodies and helminths in field populations of house mice (Mus domesticus) in southeastern Australia. Epidemiol Infect 110:399-417.
24. Smith AL. 1983. Response of weanling random-bred mice to inoculation with minute virus of mice. Lab Anim Sci 33:37-40.
25. SpearmanC.1908.The method of 'right and wrong cases'(constant stimuli) without Gauss's formulae.Br J Psychol2:227-242.
26. Thomas ML 3rd, Morse BC, O'Malley J, Davis JA, St Claire MB, Cole MN. 2007. Gender influences infectivity in C57BL/6 mice exposed to mouse minute virus. Comp Med 57:74-81.
27. Wan CH, Söderlund-Venermo M, Pintel DJ, Riley LK. 2002. Molecular characterization of three newly recognized rat parvoviruses. J Gen Virol 83:2075-2083.